rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
25157968
2014
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
25157968
2014
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.
23569304
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma.
23538902
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
23614898
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma.
23538902
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.
23414587
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.
23569304
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
23614898
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.
23414587
2013
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
SHOC2 and CRAF mediate ERK1/2 reactivation in mutant NRAS-mediated resistance to RAF inhibitor.
23076151
2012
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
SHOC2 and CRAF mediate ERK1/2 reactivation in mutant NRAS-mediated resistance to RAF inhibitor.
23076151
2012
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumors.
22761467
2012
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumors.
22761467
2012
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
20179705
2010
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
20179705
2010
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
20130576
2010
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
20130576
2010
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
18390968
2008
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
18390968
2008
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
Distinct sets of genetic alterations in melanoma.
16291983
2005
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
Distinct sets of genetic alterations in melanoma.
16291983
2005
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
Ras mutations in human melanoma: a marker of malignant progression.
8120410
1994
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
A
0.700
CausalMutation
CLINVAR
Ras mutations in human melanoma: a marker of malignant progression.
8120410
1994
rs121913255
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
melanoma
G
0.700
CausalMutation
CLINVAR
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
2674680
1989